Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors

Human Gene Therapy

Volumn 8, Issue 10, 1997, Pages 1207-1217

  Song, Wenru ^a   Kong, Hwai Loong ^a   Traktman, Paula ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOSINE DEAMINASE; THROMBOPOIETIN;

ADENOVIRUS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOCOMPETENCE; NONHUMAN; TRANSGENE;

ADENOVIRIDAE; ESCHERICHIA COLI; FELIS CATUS;

EID: 0030770344     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.10-1207     Document Type: Article

References (44)

1. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G., and MASTRANGELI, A. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229-234.
2. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
3. CHAKRABARTI, S., BRECHLING, K., and MOSS, B. (1985). Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403-3409.
4. CHEN, P.W., WANG, M., BRONTE, V., ZHAI, Y., ROSENBERG, S.A., and RESTIFO, N.P. (1996). Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156, 224-231.
5. CHO, S., SONG, W., KONG, H., and CRYSTAL, R.G. (1997). Adenovirus vector-mediated immunization against β-galactosidase prevents pulmonary metastases by β-galactosidase-expressing murine colon carcinoma cells. Am. J. Respir. Crit. Med. (in press).
6. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
7. CRYSTAL, R.G., McELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
8. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.-W., SARVETNICK, M., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
9. ERTL, H.C., and XIANG, Z. (1996). Novel vaccine approaches. J. Immunol. 156, 3579-3582.
10. FREY, B.M., CANNIZZO, S., CRYSTAL, R.G., and MOORE, M.A.S. (1996). Expression of human thrombopoietin transgene delivered by an adenovirus based strategy is dependent on host immune competence. Exp. Hematol. 24, 1056.
11. GUZMAN, R.J., HIRSCHOWITZ, E.A., BRODY, S.L., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1994). In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 91, 10732-10736.
12. HERSH, J., CRYSTAL, R.G., and BEWIG, B. (1995). Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the prdouct of a second adenovirus vector. Gene Ther. 2, 124-131.
13. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J., and CRYSTAL, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
14. JANEWAY, C.A., JR. (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Pt. 1), 1-13.
15. JUILLARD, V., VILLEFROY, P., GODFRIN, D., PAVIRANI, A., VENET, A., and GUILLET, J.G. (1995). Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur. J. Immunol. 25, 3467-3473.
16. KAPLAN, J.M., STGEORGE, J.A., PENNINGTON, S.E., KEYES, L.D., JOHNSON, R.P., WADSWORTH, S.C., and SMITH, A.E. (1996). Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR. Gene Ther. 3, 117-127.
17. KASS-EISLER, A., FALCK-PEDERSEN, E., ALVIRA, M., RIVERA, J., BUTTRICK, P.M., WITTENBERG, B.A., CIPRIANI, L., and LEINWAND, L.A. (1993). Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA 90, 11498-11502.
18. KASS-EISLER, A., FALCK-PEDERSEN, E., ELFENBEIN, D.H., ALVIRA, M., BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1, 395-402.
19. KAY, M.A., GRAHAM, F., LELAND, F., and WOO, S.L.C. (1995). Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819.
20. KOZARSKY, K.F., JOOSS, K., DONAHEE, M., STRAUSS, J.F., III, and WILSON, J.M. (1996). Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genet. 13, 54-62.
21. KRUISBEEK, A.M. (1996). Preparation of cell suspensions from spleen. Curr. Prot. Immunol. 1, 3.1.3-3.1.5.
22. LEE, M.G., ABINA, M.A., HADDADA, H., and PERRICAUDET, M. (1995). The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2, 256-262.
23. LIU, K., LEMON, B., and TRAKTMAN, P. (1995). The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J. Virol. 69, 7823-7834.
24. MACK, C.A., SONG, W., CARPENTER, H., WICKHAM, T.J., KOVESDI, I., HARVEY, B., MAGOVERN, C.J., ISOM, O.W., ROSENGART, T.K., FALCK-PEDERSEN, E., HACKETT, N.R., CRYSTAL, R.G., and MASTRANGELI, A. (1997). Circumvention of anti-adenovirus neutralizing immunity by administration of an adenovirus vector of an alternate serotype. Hum. Gene Ther. 8, 99-109.
25. MATZINGER, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
26. OHWADA, A., RAFII, S., MOORE, M.A.S., and CRYSTAL, R.G. (1996). In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression. Blood 88, 778-784.
27. PFIZENMAIER, K., PAN, S.H., and KNOWLES, B.B. (1980). Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens. J. Immunol. 124, 1888-1891.
28. RAWLE, F.C., KNOWLES, B.B., RICCIARDI, R.P., BRAHMACHERI, V., DUERKSEN-HUGHES, P., WOLD, W.S., and GOODING, L.R. (1991). Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1a is immunodominant in H-2b, but not in H-2d or H-2k mice. J. Immunol. 146, 3977-3984.
29. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
30. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
31. SETOGUCHI, Y., JAFFE, H.A., CHU, C.S., and CRYSTAL, R.G. (1994). Intraperitoneal in vivo gene therapy to deliver alpha 1-anti-trypsin to the systemic circulation. Am. J. Respir. Cell. Mol. Biol. 10, 369-377.
32. SONG, W., COLLISSON, E.W., BILLINGSLEY, P.M., and BROWN, W.C. (1992). Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66, 5409-5417.
33. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
34. WILSON, J.M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187.
35. XIANG, Z.Q., YANG, Y., WILSON, J.M., and ERTL, H.C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227.
36. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adenoassociated virus. J. Virol. 70, 8098-8108.
37. YANG, Y., ERTL, H.C., and WILSON, J.M. (1994a). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.
38. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994b). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
39. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994c). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
40. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
41. YANG, Y., JOOSS, K.U., SU, Q., ERTL, H.C.J., and WILSON, J.M. (1996a). Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144.
42. YANG, Y., SU, Q., and WILSON, J.M. (1996b). Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209-7212.
43. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
44. ZHAI, Y., YANG, J.C., KAWAKAMI, Y., SPIESS, P., WADSWORTH, S.C., CARDOZA, L.M., COUTURE, L.A., SMITH, A.E., and ROSENBERG, S.A. (1996). Antigen-specific tumor vaccines, development and characterization of recombinant adenoviruses encoding martl or gp100 for cancer therapy. J. Immunol. 156, 700-710.